SOX10 and myoepithelial tumor: In the study by Baneckova et al. SOX-10 and S1009 protein expression was evaluated in 89 benign tumors, including 74 oncocytomas, 15 pleomorphic adenomas (PA), and myoepitheliomas (ME) with oncocytic metaplasia.